Skip to content

Postoperative Progression of the Disease Following Extensive Versus Limited Mesenteric Excision for Crohn's Disease

The MESOCOLIC Trial: Mesenteric Excision Surgery or Conservative Limited Resection in Crohn's Disease

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03769922
Enrollment
116
Registered
2018-12-10
Start date
2019-02-18
Completion date
2025-01-31
Last updated
2019-02-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Postoperative Surgical Recurrence

Brief summary

The study evaluates whether there is a reduction in the rate of postoperative progression of the disease following extensive mesenteric excision (EME), when compared to that of limited mesenteric excision (LME), in patients undergoing ileocolic resection for Crohn's disease. Half of participants will receive EME, while the other half will receive LME.

Detailed description

EME and LME are the two surgical procedures which are commonly used in the treatment of Crohn's disease. However, the areas of the mesenteric tissue resected are different. EME means that the mesentery is resected avoiding the root region, i.e. 1 cm from the root of ileocolic artery and vein. LME represents that the mesentery is retained, i.e. Close shave or 3 cm from the border of bowel (using whatever approach - clips, or haemostatic vessel sealing device).

Interventions

PROCEDUREExtensive mesenteric resection

The mesentery is resected avoiding the root region.

PROCEDURELimited mesenteric excision

The mesentery is retained.

Sponsors

The Cleveland Clinic
CollaboratorOTHER
University Hospital of Limerick
CollaboratorOTHER
Sixth Affiliated Hospital, Sun Yat-sen University
CollaboratorOTHER
Sir Run Run Shaw Hospital
CollaboratorOTHER
Jinling Hospital, China
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Subject)

Eligibility

Sex/Gender
ALL
Age
16 Years to 65 Years
Healthy volunteers
No

Inclusion criteria

* Patients with Crohn's disease limited to the distal ileum and/or right colon receiving their index ileocolonic resection * Patients with a documented history of Crohn's disease based on endoscopic, radiological, or histological criteria

Exclusion criteria

* Pregnancy or willingness to become pregnant in the following year * Previous ileocolic resection history * Patients having Crohn's disease lesion at a gastrointestinal site other than the terminal ileum cecum, or right colon * Patients having an internal fistula which required resection of another segment of bowel

Design outcomes

Primary

MeasureTime frameDescription
Accumulated 5-year postoperative surgical recurrence5 years after the first surgeryThe requirement for repeat surgery for a Crohn's disease related indication.

Secondary

MeasureTime frameDescription
Accumulated 5-year endoscopic recurrence5 years after the first surgeryDisease proximal to the anastomosis or in the perianastomotic are considered to be a endoscopic recurrence (Rutgeert's score i2, or higher, disease in other sites is not considered recurrence)
Accumulated 5-year clinical recurrence5 years after the first surgeryThe presence of endoscopic disease (i2, or higher) or radiological evidence plus the presence of symptoms attributable to Crohn's disease that are severe enough to require medical or surgical treatment.

Other

MeasureTime frameDescription
postoperative operation-related complications30 day30-day postoperative morbidity

Countries

China

Contacts

Primary ContactLi Yi, PhD
liyi.jlh@hotmail.com+86 13851843735

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 28, 2026